-
Walgreens riding out economic storm, propelling surge in chain’s stock price
It could have been so much worse.
That conclusion, apparently, is what investors drew from Walgreens’ sales and earnings report for the second quarter ended Feb. 28. And it was enough to push the company’s stock price up sharply and burnish the investment outlook for other drug retailers: even Rite Aid’s stock price responded with a nice up-tick.
-
Drug Fair Group files for bankruptcy
The retail pharmacy universe just got a little bit smaller.
Despite Drug Fair’s turnaround efforts in recent years, the regional player has fallen victim to the current economic crunch, filing for bankruptcy protection and agreeing to sell the majority of its assets to Walgreens.